BASELINE INTERLEUKIN-17A PREDICT TREATMENT RESPONSE TO TOCILIZUMAB AND DISEASE-MODIFYING ANTIRHEUMATIC DRUGS THERAPY

被引：0

作者：

Lee, S. J. ^{[1
,2
,3
]}

Yoon, M. J. ^{[3
]}

Joo, S. H. ^{[3
]}

Park, W. ^{[4
]}

Park, S. H. ^{[5
]}

Shim, S. C. ^{[6
]}

Baek, H. J. ^{[7
]}

Yoo, D. -H. ^{[8
]}

Kim, H. A. ^{[9
]}

Lee, S. K. ^{[10
]}

Lee, Y. J. ^{[11
]}

Park, Y. E. ^{[12
]}

Cha, H. -S. ^{[13
]}

Choi, I. A. ^{[14
]}

Lee, E. Y. ^{[1
,2
]}

Lee, E. B. ^{[1
,2
]}

Song, Y. W. ^{[1
,2
,3
]}

机构：

[1] Seoul Natl Univ, WCU, Grad Sch Convergence Sci & Technol, Seoul, South Korea

[2] Seoul Natl Univ, Coll Med, Med Res Inst, Seoul, South Korea

[3] Seoul Natl Univ Hosp, Div Rheumatol, Seoul 110744, South Korea

[4] Inha Univ Hosp, Div Rheumatol, Seoul, South Korea

[5] Catholic Univ Korea, Seoul St Marys Hosp, Div Rheumatol, Seoul, South Korea

[6] Eulji Univ Hosp, Div Rheumatol, Taejon, South Korea

[7] Gachon Univ, Gil Med Ctr, Div Rheumatol, Inchon, South Korea

[8] Hanyang Univ, Med Ctr, Div Rheumatol, Seoul 133791, South Korea

[9] Hallym Univ, Med Ctr, Div Rheumatol, Seoul, South Korea

[10] Yonsei Univ Hlth Syst, Div Rheumatol, Seoul, South Korea

[11] Seoul Natl Univ, Bundang Hosp, Div Rheumatol, Seoul, South Korea

[12] Pusan Natl Univ Hosp, Div Rheumatol, Pusan, South Korea

[13] Sam Sung Med Ctr, Div Rheumatol, Seoul, South Korea

[14] Chung Buk Natl Univ Hosp, Div Rheumatol, Cheongju, South Korea

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷

关键词：

D O I：

10.1136/annrheumdis-2014-eular.5095

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SAT0059

引用

页码：610 / 611

页数：2

共 50 条

[1] Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy Study
Genovese, Mark C.
McKay, James D.
Nasonov, Evgeny L.
Mysler, Eduardo F.
da Silva, Nilzio A.
Alecock, Emma
Woodworth, Thasia
Gomez-Rein, Juan J.
ARTHRITIS AND RHEUMATISM, 2008, 58 (10): : 2968 - 2980
[2] Disease-modifying antirheumatic drugs
Lambert, David G.
ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2012, 13 (03): : 128 - 130
[3] DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
STECHER, VJ
CARLSON, JA
CONNOLLY, KM
BAILEY, DM
MEDICINAL RESEARCH REVIEWS, 1985, 5 (03) : 371 - 390
[4] Disease-Modifying Antirheumatic Drugs
Brasington, Richard
JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 2009, 34A (02): : 347 - 348
[5] Disease-modifying antirheumatic drugs
Lambert, David G.
ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2009, 10 (01): : 35 - 37
[6] Disease-modifying antirheumatic drugs
Slack, S
Furst, DE
DRUGS OF TODAY, 1996, 32 (06) : 463 - 476
[7] DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
SMITH, MD
AHERN, MJ
MEDICAL JOURNAL OF AUSTRALIA, 1992, 157 (11-12) : 797 - 801
[8] Modern disease-modifying antirheumatic drugs
Mueller-Ladner, U.
Richter, K.
Tarner, I. H.
INTERNIST, 2015, 56 (03): : 307 - 314
[9] Effects Of Tocilizumab On Serum Cytokines In Rheumatoid Arthritis With An Inadequate Response To Disease-Modifying Antirheumatic Drugs.
Lee, Sang Jin
Kim, Kyung Rok
Joo, Sang Hyun
Lee, Jae Myung
Choi, In Ah
Lee, Joo Youn
Yoo, Hyun Jung
Lee, Eun Young
Lee, Eun Bong
Park, Won
Park, Sung Hwan
Shim, Seung-Cheol
Yoo, Dae-Hyun
Baek, Han Joo
Kim, Hyun Ah
Lee, Soo Kon
Lee, Yun Jong
Park, Young Eun
Cha, Hoon-Suk
Song, Yeong Wook
ARTHRITIS AND RHEUMATISM, 2013, 65 : S611 - S611
[10] PROTOCOL DEVELOPMENT FOR COMBINATION THERAPY WITH DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
PAULUS, HE
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1993, 23 (02) : 19 - 25

← 1 2 3 4 5 →